Prosiectau (12564)
Cardiff University Schools involved in this Project
Targeting Ref1/STAT3 to treat Tuberous Sclerosis (01.04.2018 - 09.02.2023)
- Tee, Andrew
Targeting the allosteric control of alarmone synthetases to tackle bacteria persistence (01.10.2017 - 15.01.2020)
- Jin, Yi
Targeting the CD8 coreceptor as a novel strategy for the treatment of type 1 diabetes (01.01.2013 - 31.12.2013)
Targeting the early endosome as a therapeutic strategy in neurodegenerative diseases (01.01.2024 - 14.04.2027)
- Connor-Robson, Natalie
Targeting the pathological pathways to Parkinson's (02.05.2018 - 01.08.2021)
- Webber, Caleb
Targeting the terminal pathway in complement - driven disease (30.06.2018 - 30.09.2018)
- Morgan, Paul
Targeting the terminal pathway in complement-driven disease (01.10.2016 - 30.09.2018)
- Morgan, Paul
Targeting the Wnt receptor frizzled-7 for the treatment of gastric cancer (01.09.2018 - 31.08.2021)
- Phesse, Toby
Targeting tissue macrophage generation during inflammation as a mechanism to modulate the resolution of inflammation (31.07.2012 - 30.07.2015)
- Taylor, Philip
Targeting Wnt signaling to treat metastatic prostate cancer (01.09.2021 - 31.07.2025)
- Phesse, Toby